Savings Effect

SudarshanChem reports its Q2 results; --Revenue Up 14.9% At ₹2,742 Cr Vs ₹2,387 Cr (YoY) --Net Profit At ₹28 Cr Vs ₹12 Cr (YoY) --EBITDA At ₹268 Cr Vs ₹132 Cr (YoY) --EBITDA Margin Up 420 Bps At 9.7% Vs 5.5% (YoY)

SudarshanChem reports its Q2 results; --Revenue Up 14.9% At ₹2,742 Cr Vs ₹2,387 Cr (YoY) --Net Profit At ₹28 Cr Vs ₹12 Cr (YoY) --EBITDA At ₹268 Cr Vs ₹132 Cr (YoY) --EBITDA Margin Up 420 Bps At 9.7% Vs 5.5% (YoY)

ANUP ENGINEEERING: CO CFO RESIGNS WITH IMMEDIATE EFFECT

HAVELLS INDIA LTD: CO. RECEIVES LETTER OF COMFORT FOR FISCAL INCENTIVES UNDER UP GLOBAL CAPABILITY CENTRES POLICY 2024; PROPOSED INVESTMENT OF ₹879 CRORES FOR R&D CENTRE IN NOIDA; INCENTIVES INCLUDE 25% OF ELIGIBLE CAPITAL INVESTMENT UP TO ₹25 CRORES PER ANNUM.

LIC: CO SAYS H2 WILL BE STRONGER THEN H1 VNB MARGINS WILL IMPROVE OVERALL STRONG GROWTH TO BE SEEN IN COMING QTRS: INTERVIEW

3MINDIA: Q2 STANDALONE NET PROFIT 1.58B RUPEES VS 1.91B (YOY) 3MINDIA: Q2 EBITDA 2.23B RUPEES VS 2.56B (YOY); Q2 EBITDA MARGIN 15.36% VS 20.20% (YOY) 3MINDIA: Q2 REVENUE 14.52B RUPEES VS 12.66B (YOY)

#TataPower In Focus | Kleros Capital Says SICC Grants Enforcement Orders To Seize Co’s Shares In S’pore Arms To Pay Kleros Cap Alert: SICC Is Singapore International Commercial Court

PYRAMID: Q2 CONS NET PROFIT 95M RUPEES VS 61.5M (YOY) PYRAMID: Q2 EBITDA 195.4M RUPEES VS 119.3M (YOY); Q2 EBITDA MARGIN 8.21% VS 7.42% (YOY) PYRAMID: Q2 REVENUE 2.38B RUPEES VS 1.61B (YOY)

SML MAHINDRA LIMITED: BOARD APPROVES RIGHTS ISSUE TO RAISE UP TO ₹1450 CRORE; SUBJECT TO REGULATORY APPROVALS AND DETERMINATION OF TERMS.

ELGIEQUIP: Q2 CONS NET PROFIT 1.28B RUPEES VS 1.21B (YOY) ELGIEQUIP: Q2 EBITDA 1.85B RUPEES VS 1.4B (YOY); Q2 EBITDA MARGIN 16.31% VS 14.45% (YOY) ELGIEQUIP: Q2 REVENUE 11.34B RUPEES VS 9.68B (YOY)

VTL: Q2 CONS NET PROFIT 3.57B RUPEES VS 1.87B (YOY) VTL: Q2 EBITDA 5.61B RUPEES VS 3.34B (YOY); Q2 EBITDA MARGIN 19.58% VS 13.48% (YOY) VTL: Q2 REVENUE 28.66B RUPEES VS 24.8B (YOY)

ANUP: Q2 CONS NET PROFIT 65.8M RUPEES VS 320.5M (YOY) ANUP: Q2 EBITDA 174.4M RUPEES VS 514.8M (YOY); Q2 EBITDA MARGIN 9.56% VS 22.16% (YOY) ANUP: Q2 REVENUE 1.82B RUPEES VS 2.32B (YOY)

ASHAPURA MINECHEM: Q2 CONS NET PROFIT 520M RUPEES VS 960M (YOY) ASHAPURA MINE: Q2 EBITDA 1.25B RUPEES VS 1.3B (YOY); Q2 EBITDA MARGIN 11.8% VS 13.7% (YOY) ASHAPURA MINECHEM: Q2 REVENUE 10.6B RUPEES VS 9.5B (YOY)

VOEPL: Q2 CONS NET PROFIT 27M RUPEES VS LOSS 39M (YOY) VOEPL: Q2 EBITDA 198M RUPEES VS 101M (YOY); Q2 EBITDA MARGIN 11.2% VS 10.3% (YOY) VOEPL: Q2 REVENUE 1.8B RUPEES VS 978M (YOY)

FORTIS: CO EXPECT HOSPITAL EBITDA MARGINS TO REMAIN IN PRESSURE IN FY27; MANAGEMENT WITHHOLDS FUTURE GUIDANCE AMID UNCERTAINTY OVER ONCOLOGY DRUG PRICE CAPS

POWER MECH PROJECTS: CO BAGS AN INTERNATIONAL ORDER WORTH ₹492 CR

GODREJAGRO: Q2 CONS NET PROFIT 1.15B RUPEES VS 925.9M (YOY) GODREJAGRO: Q2 EBITDA 2.24B RUPEES VS 2.31B (YOY); Q2 EBITDA MARGIN 7.49% VS 8.99% (YOY) GODREJAGRO: Q2 REVENUE 29.95B RUPEES VS 25.67B (YOY)

THERMAX: CO TO SEE REVENUE ABOVE RS 70B BETWEEN Q3, Q4 VS 28B IN Q2

NACL Q2 --Net Loss At ₹1.4 Cr Vs Profit Of ₹2.5 Cr (YoY) --Revenue Down 18.2% At ₹374 Cr Vs ₹457 Cr (YoY) --EBITDA Down 74% At ₹12 Cr Vs ₹45 Cr (YoY) --Margin At 3% Vs 10% (YoY)